These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 35806096)

  • 1. Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction.
    Goh KK; Chen CY; Wu TH; Chen CH; Lu ML
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxytocin system dysfunction as a common mechanism underlying metabolic syndrome and psychiatric symptoms in schizophrenia and bipolar disorders.
    Quintana DS; Dieset I; Elvsåshagen T; Westlye LT; Andreassen OA
    Front Neuroendocrinol; 2017 Apr; 45():1-10. PubMed ID: 28049009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxytocin and Social Cognitions in Schizophrenia: A Systematic Review.
    Bukovskaya O; Shmukler A
    Psychiatr Q; 2016 Sep; 87(3):521-43. PubMed ID: 26689706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oxytocin model of formation of psychotic symptoms and its implications for research on oxytocinergic pathway in schizophrenia].
    Holka-Pokorska J; Jarema M
    Psychiatr Pol; 2014; 48(1):19-33. PubMed ID: 24946432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Hypotheses on the High Incidence of Dementia in Psychotic Disorders.
    Jonas K; Abi-Dargham A; Kotov R
    JAMA Psychiatry; 2021 Dec; 78(12):1305-1306. PubMed ID: 34524413
    [No Abstract]   [Full Text] [Related]  

  • 6. Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis.
    Bürkner PC; Williams DR; Simmons TC; Woolley JD
    Schizophr Bull; 2017 Oct; 43(6):1291-1303. PubMed ID: 28586471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin and sexual function in males and females with schizophrenia.
    Wehring HJ; Buchanan RW; Feldman S; Carpenter WT; McMahon RP; Weiner E; Gold JM; Adams HA; Strauss GP; Rubin LH; Kelly DL
    Schizophr Res; 2018 Sep; 199():431-432. PubMed ID: 29551232
    [No Abstract]   [Full Text] [Related]  

  • 8. The mechanism of life-threatening water imbalance in schizophrenia and its relationship to the underlying psychiatric illness.
    Goldman MB
    Brain Res Rev; 2009 Oct; 61(2):210-20. PubMed ID: 19595703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxytocin system dysfunction in patients with treatment-resistant schizophrenia: Alterations of blood oxytocin levels and effect of a genetic variant of OXTR.
    Nakata Y; Kanahara N; Kimura A; Niitsu T; Komatsu H; Oda Y; Nakamura M; Ishikawa M; Hasegawa T; Kamata Y; Yamauchi A; Inazumi K; Kimura H; Shiko Y; Kawasaki Y; Iyo M
    J Psychiatr Res; 2021 Jun; 138():219-227. PubMed ID: 33866050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia.
    Buchanan RW; Kelly DL; Weiner E; Gold JM; Strauss GP; Koola MM; McMahon RP; Carpenter WT
    J Clin Psychopharmacol; 2017 Aug; 37(4):394-400. PubMed ID: 28590362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of oxytocin and vasopressin in central nervous system activity and mental disorders].
    Wójciak P; Remlinger-Molenda A; Rybakowski J
    Psychiatr Pol; 2012; 46(6):1043-52. PubMed ID: 23479945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Membrane lipids in schizophrenia and early phases of psychosis: Potential biomarkers and therapeutic targets?].
    Frajerman A; Kebir O; Chaumette B; Tessier C; Lamazière A; Nuss P; Krebs MO
    Encephale; 2020 Jun; 46(3):209-216. PubMed ID: 32151446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oxytocin and genetic variants on brain and behaviour: Implications for treatment in schizophrenia.
    Bartholomeusz CF; Ganella EP; Labuschagne I; Bousman C; Pantelis C
    Schizophr Res; 2015 Nov; 168(3):614-27. PubMed ID: 26123171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oxytocin on empathy, introspective accuracy, and social symptoms in schizophrenia: A 12-week twice-daily randomized controlled trial.
    Halverson T; Jarskog LF; Pedersen C; Penn D
    Schizophr Res; 2019 Feb; 204():178-182. PubMed ID: 30243853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare missense coding variants in oxytocin receptor (OXTR) in schizophrenia cases are associated with early trauma exposure, cognition and emotional processing.
    Veras AB; Getz M; Froemke RC; Nardi AE; Alves GS; Walsh-Messinger J; Chao MV; Kranz TM; Malaspina D
    J Psychiatr Res; 2018 Feb; 97():58-64. PubMed ID: 29190530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional connectivity in distinct cognitive subtypes in psychosis.
    Lewandowski KE; McCarthy JM; Öngür D; Norris LA; Liu GZ; Juelich RJ; Baker JT
    Schizophr Res; 2019 Feb; 204():120-126. PubMed ID: 30126818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia.
    Pedersen CA; Gibson CM; Rau SW; Salimi K; Smedley KL; Casey RL; Leserman J; Jarskog LF; Penn DL
    Schizophr Res; 2011 Oct; 132(1):50-3. PubMed ID: 21840177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey.
    Suvisaari JM; Saarni SI; Perälä J; Suvisaari JV; Härkänen T; Lönnqvist J; Reunanen A
    J Clin Psychiatry; 2007 Jul; 68(7):1045-55. PubMed ID: 17685741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 fatty acids ameliorate cognitive dysfunction in schizophrenia patients with metabolic syndrome.
    Tang W; Wang Y; Xu F; Fan W; Zhang Y; Fan K; Wang W; Zhang Y; Zhang C
    Brain Behav Immun; 2020 Aug; 88():529-534. PubMed ID: 32304881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating.
    Feifel D; Reza T
    Psychopharmacology (Berl); 1999 Jan; 141(1):93-8. PubMed ID: 9952070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.